A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer
Clinical trial NCT02465593 · TERMINATED
Trial details
- NCT number
- NCT02465593
- Sponsor
- PharmaEngine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2021-07-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.